Publications
Detailed Information
Simvastatin acts as an inhibitor of interferon gamma-induced cycloxygenase-2 expression in human THP-1 cells, but not in murine RAW264.7 cells
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Chang Seok | - |
dc.contributor.author | Shin, Yong Jae | - |
dc.contributor.author | Won, Cheolhee | - |
dc.contributor.author | Lee, Yun-Song | - |
dc.contributor.author | Ye, Sang-Kyu | - |
dc.contributor.author | Chung, Myung-Hee | - |
dc.contributor.author | Park, Chung-Gyu | - |
dc.date.accessioned | 2012-07-02T08:34:27Z | - |
dc.date.available | 2012-07-02T08:34:27Z | - |
dc.date.issued | 2009-08 | - |
dc.identifier.citation | BIOCELL; Vol.33 2; 107-114 | ko_KR |
dc.identifier.issn | 0327-9545 | - |
dc.identifier.uri | https://hdl.handle.net/10371/78128 | - |
dc.description.abstract | Cyclooxygenase-2 (COX-2) is a key inflammatory response molecule,,in(] associated with Many immune functions of monocytes/macrophages. Particularly, interferon gamma (IFN gamma)-induced COX-2 expression appears in inflammatory conditions such as viral infection and autoimmune diseases. Recently statins have been reported to show variable effects oil COX-2 expression, and oil their cell and species type dependences. Based on the above description, we compared the effect of simvastatin on IFN gamma-induced COX-2 expression in human monocytes versus murine macrophages. In a result, we found that simvastatin suppresses IFN gamma-induced COX-2 expression in human THP-1 monocytes, but rather, potentiates IFN gamma-induced COX-2 expression in murine RAW264.7 macrophages. However, signal transducer and activator of transcription 1/3 (STAT1/3), known as a transcription factor oil COX-2 expression, is inactivated by simvastatin in both cells. Our findings showed that simvastatin is likely to Suppress IFN gamma-induced COX-2 expression by inhibiting STAT1/3 activation in human THP-1 cells, but not in murine RAW264.7 cells. Thus, we concluded that IFN gamma-induced COX-2 expression is differently regulated by simvastatin depending oil species specific mechanism. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | Universidad Nacional de Cuyo | ko_KR |
dc.subject | monocyte | ko_KR |
dc.subject | SOCS 1/3 | ko_KR |
dc.subject | macrophage | ko_KR |
dc.subject | INF gamma | ko_KR |
dc.subject | STAT 1/3 | ko_KR |
dc.title | Simvastatin acts as an inhibitor of interferon gamma-induced cycloxygenase-2 expression in human THP-1 cells, but not in murine RAW264.7 cells | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 이창석 | - |
dc.contributor.AlternativeAuthor | 신용재 | - |
dc.contributor.AlternativeAuthor | 원철희 | - |
dc.contributor.AlternativeAuthor | 이윤송 | - |
dc.contributor.AlternativeAuthor | 박정규 | - |
dc.contributor.AlternativeAuthor | 예상규 | - |
dc.contributor.AlternativeAuthor | 정명희 | - |
dc.citation.journaltitle | BIOCELL | - |
dc.description.citedreference | Lee SJ, 2007, J LEUKOCYTE BIOL, V82, P436, DOI 10.1189/jlb.1206739 | - |
dc.description.citedreference | Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023 | - |
dc.description.citedreference | Kim YS, 2007, J CARDIOVASC PHARM, V49, P376 | - |
dc.description.citedreference | Habib A, 2007, FASEB J, V21, P1665, DOI 10.1096/fj.06-6766com | - |
dc.description.citedreference | Yano M, 2007, CIRC RES, V100, P1442, DOI 10.1161/01.RES.0000268411.49545.9c | - |
dc.description.citedreference | Chello M, 2007, ANN THORAC SURG, V83, P1374, DOI 10.1016/j.athoracsur.2006.10.065 | - |
dc.description.citedreference | Tunon J, 2007, EXPERT OPIN THER TAR, V11, P273, DOI 10.1517/14728222.11.3.273 | - |
dc.description.citedreference | Greenwood J, 2007, TRENDS IMMUNOL, V28, P88 | - |
dc.description.citedreference | Ghittoni R, 2006, EUR J IMMUNOL, V36, P2885, DOI 10.1002/eji.200636567 | - |
dc.description.citedreference | Kuipers HF, 2005, HUM IMMUNOL, V66, P653, DOI 10.1016/j.humimm.2005.04.004 | - |
dc.description.citedreference | Chen JC, 2004, EXP CELL RES, V301, P305, DOI 10.1016/j.yexcr.2004.05.039 | - |
dc.description.citedreference | Qing YL, 2004, J BIOL CHEM, V279, P41679, DOI 10.1074/jbc.M406413200 | - |
dc.description.citedreference | KOBASHIGAWA JA, 2004, SEMIN VASC MED, V4, P401 | - |
dc.description.citedreference | Miller LJ, 2004, ANN PHARMACOTHER, V38, P91, DOI 10.1345/aph.1D104 | - |
dc.description.citedreference | LIAO JK, 2004, INT J CLIN PRACT, V143, P41 | - |
dc.description.citedreference | Huang KC, 2003, FEBS LETT, V555, P385, DOI 10.1016/S0014-5793(03)01297-3 | - |
dc.description.citedreference | Monick MM, 2003, J IMMUNOL, V171, P2625 | - |
dc.description.citedreference | Huang KC, 2003, J BIOMED SCI, V10, P396, DOI 10.1159/000071159 | - |
dc.description.citedreference | Xuan YT, 2003, J MOL CELL CARDIOL, V35, P525, DOI 10.1016/S0022-2828(03)00076-2 | - |
dc.description.citedreference | Chung HK, 2002, EXP MOL MED, V34, P451 | - |
dc.description.citedreference | Degraeve F, 2001, J BIOL CHEM, V276, P46849, DOI 10.1074/jbc.M104197200 | - |
dc.description.citedreference | Sadeghi MM, 2001, TRANSPLANTATION, V71, P1262 | - |
dc.description.citedreference | Kiener PA, 2001, INT IMMUNOPHARMACOL, V1, P105 | - |
dc.description.citedreference | Grip O, 2000, EUR J PHARMACOL, V410, P83 | - |
dc.description.citedreference | Chen H, 2000, HYPERTENSION, V36, P923 | - |
dc.description.citedreference | Yasukawa H, 2000, ANNU REV IMMUNOL, V18, P143 | - |
dc.description.citedreference | Ortego M, 1999, ATHEROSCLEROSIS, V147, P253 | - |
dc.description.citedreference | Inoue H, 1998, BIOCHEM BIOPH RES CO, V244, P143 | - |
dc.description.citedreference | Decker T, 1997, J INTERF CYTOK RES, V17, P121 | - |
dc.description.tc | 2 | - |
- Appears in Collections:
- Files in This Item:
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.